Medlive Technology Co (HKSE:02192) Median PS Value : HK$0.00 (As of May. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Medlive Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.613. Medlive Technology Co's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is HK$0.00.

As of today (2024-05-25), Medlive Technology Co's share price is HK$7.63. Medlive Technology Co's Median PS Value is HK$0.00. Therefore, Medlive Technology Co's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Medlive Technology Co's Median PS Value or its related term are showing as below:

HKSE:02192's Price-to-Median-PS-Value is not ranked ^*
in the Medical Distribution industry.
Industry Median: 0.905
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Medlive Technology Co Median PS Value Historical Data

The historical data trend for Medlive Technology Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Median PS Value Chart

Medlive Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Median PS Value

Get a 7-Day Free Trial

Medlive Technology Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Median PS Value	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Medlive Technology Co's Median PS Value

For the Medical Distribution subindustry, Medlive Technology Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlive Technology Co's Price-to-Median-PS-Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Price-to-Median-PS-Value falls into.

Medlive Technology Co Median PS Value Calculation

Medlive Technology Co's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0.613	*	0
	=	0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.613.

Medlive Technology Co (HKSE:02192) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Medlive Technology Co's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	7.63	/	0.00
	=

Medlive Technology Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlive Technology Co (HKSE:02192) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN

Website

https://www.medlive.cn

Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
M3, Inc.	2101 Beneficial owner
Sony Group Corporation	2201 Interest of corporation controlled by you
Tian Liping
Zhang Xiaofeng	2101 Beneficial owner
Liu Lingdi	2101 Beneficial owner
Tian Lixin	2101 Beneficial owner
Brown Brothers Harriman & Co.	2502 Approved lending agent
Fidelity Funds	2101 Beneficial owner
Tiantian Co., Limited

Medlive Technology Co (HKSE:02192) Headlines

No Headlines